PATENT CLAIM ANALYSIS

Application Number: 15987005
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["424", "078370"]

Abstract:
A use of a polymer as a synergist for a chemotherapeutic drug, wherein the polymer is a polymer having a 1,2-dicarboxylic acid monoamide structure, and after the polymer, a chemotherapeutic drug and a cancer cell are co-incubated in a slightly acidic environment which simulates a tumor tissue, a survival rate of the cancer cell is lower than that of a cancer cell incubated under the same conditions without the polymer. The polymer and the chemotherapeutic drug are injected together into a tumor-bearing animal body, the tumor-growth inhibiting effect thereof is better than that with injection of the same dosage of the chemotherapeutic drug alone.

Claim (Index 5):
The use of a polymer as a synergist for a chemotherapeutic drug according to  claim 3 , wherein the average molecular weight of the linear polymer containing the primary and/or secondary amine group, the branched polymer and the hyperbranched polymer is ranged between 1,000 Da and 1,000,000 Da; and the generation number of the dendrimer is ranged from 2 to 10.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 93.0
- Lexical Diversity: 1.85
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15698486', '12600977', '13642868', '15713401', '15516378']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6464826398839092
- 35 USC 102 Novelty (BERT): 0.4971225221519533
- Combined Prediction Score: 0.6315466281107137
- Mean Citation Score: 198.74266
- Max Citation Score: 207.03062
- Similarity Product: 139.95642559850216

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test